{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T21:09:26Z","timestamp":1791148166585,"version":"4.1.0"},"reference-count":100,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2007,1,1]],"date-time":"2007-01-01T00:00:00Z","timestamp":1167609600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2007,1]]},"DOI":"10.1016\/j.vaccine.2006.07.052","type":"journal-article","created":{"date-parts":[[2006,8,9]],"date-time":"2006-08-09T12:34:17Z","timestamp":1155126857000},"page":"466-480","source":"Crossref","is-referenced-by-count":77,"title":["Development of an OspC-based tetravalent, recombinant, chimeric vaccinogen that elicits bactericidal antibody against diverse Lyme disease spirochete strains"],"prefix":"10.1016","volume":"25","author":[{"given":"Christopher G.","family":"Earnhart","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric L.","family":"Buckles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard T.","family":"Marconi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2006.07.052_bib1","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1126\/science.7043737","article-title":"Lyme disease\u2014a tick-borne spirochetosis?","volume":"216","author":"Burgdorfer","year":"1982","journal-title":"Science"},{"key":"10.1016\/j.vaccine.2006.07.052_bib2","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1056\/NEJM198303313081302","article-title":"Spirochetes isolated from the blood of two patients with Lyme disease","volume":"308","author":"Benach","year":"1983","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2006.07.052_bib3","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1093\/infdis\/163.2.305","article-title":"The prevalence and incidence of clinical and asymptomatic Lyme borreliosis in a population at risk","volume":"163","author":"Fahrer","year":"1991","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2006.07.052_bib4","doi-asserted-by":"crossref","first-page":"685","DOI":"10.7326\/0003-4819-86-6-685","article-title":"Erythema chronicum migrans and Lyme arthritis. The enlarging clinical spectrum","volume":"86","author":"Steere","year":"1977","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.vaccine.2006.07.052_bib5","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1002\/art.1780200102","article-title":"Lyme arthritis: an epidemic of oligoarticular arthritis in children and adults in three Connecticut communities","volume":"20","author":"Steere","year":"1977","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.vaccine.2006.07.052_bib6","first-page":"437","article-title":"Characterization of Borrelia burgdorferi strains in Lyme arthritis","volume":"24","author":"Eiffert","year":"1998","journal-title":"Scand J Infect Dis"},{"issue":"2","key":"10.1016\/j.vaccine.2006.07.052_bib7","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1038\/nri1267","article-title":"Elucidation of Lyme arthritis","volume":"4","author":"Steere","year":"2004","journal-title":"Nat Rev Immunol"},{"issue":"3","key":"10.1016\/j.vaccine.2006.07.052_bib8","first-page":"454","article-title":"Lyme disease: an infectious and postinfectious syndrome","volume":"21","author":"Asch","year":"1994","journal-title":"J Rheumatol"},{"issue":"5","key":"10.1016\/j.vaccine.2006.07.052_bib9","first-page":"503","article-title":"Cardiac manifestations of Lyme disease: a review","volume":"12","author":"Nagi","year":"1996","journal-title":"Can J Cardiol"},{"issue":"2","key":"10.1016\/j.vaccine.2006.07.052_bib10","first-page":"263","article-title":"Kinetics of Borrelia burgdorferi dissemination and evolution of disease after intradermal inoculation of mice","volume":"139","author":"Barthold","year":"1991","journal-title":"Am J Pathol"},{"issue":"2","key":"10.1016\/j.vaccine.2006.07.052_bib11","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1053\/spid.2003.127229","article-title":"Central nervous system Lyme disease","volume":"14","author":"Nachman","year":"2003","journal-title":"Semin Pediatr Infect Dis"},{"issue":"2","key":"10.1016\/j.vaccine.2006.07.052_bib12","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/S0025-7125(03)00086-5","article-title":"Neurologic aspects of Lyme disease","volume":"86","author":"Coyle","year":"2002","journal-title":"Med Clin North Am"},{"key":"10.1016\/j.vaccine.2006.07.052_bib13","doi-asserted-by":"crossref","first-page":"321","DOI":"10.3201\/eid0503.990302","article-title":"The cost effectiveness of vaccinating against Lyme disease","volume":"5","author":"Meltzer","year":"1999","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.vaccine.2006.07.052_bib14","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1001\/archinte.161.4.554","article-title":"The cost-effectiveness of vaccination against Lyme disease","volume":"161","author":"Shadick","year":"2001","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.vaccine.2006.07.052_bib15","doi-asserted-by":"crossref","first-page":"2774","DOI":"10.1128\/IAI.61.7.2774-2779.1993","article-title":"Association of treatment resistant chronic Lyme arthritis with HLA-DR4 and antibody reactivity to OspA and OspB of Borrelia burgdorferi","volume":"61","author":"Kalish","year":"1993","journal-title":"Infect Immun"},{"issue":"2","key":"10.1016\/j.vaccine.2006.07.052_bib16","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.jmb.2005.04.066","article-title":"Structure-based design of a second-generation Lyme disease vaccine based on a C-terminal fragment of Borrelia burgdorferi OspA","volume":"350","author":"Koide","year":"2005","journal-title":"J Mol Biol"},{"issue":"5","key":"10.1016\/j.vaccine.2006.07.052_bib17","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1073\/pnas.0305680101","article-title":"An effective second-generation outer surface protein A-derived Lyme vaccine that eliminates a potentially autoreactive T cell epitope.","volume":"101","author":"Willett","year":"2004","journal-title":"Proc Natl Acad Sci USA"},{"issue":"10","key":"10.1016\/j.vaccine.2006.07.052_bib18","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1016\/S1286-4579(01)01435-6","article-title":"Analysis of Borrelia burgdorferi gene expression during life cycle phases of the tick vector Ixodes scapularis","volume":"3","author":"Gilmore","year":"2001","journal-title":"Microbes Infect"},{"issue":"7","key":"10.1016\/j.vaccine.2006.07.052_bib19","doi-asserted-by":"crossref","first-page":"2909","DOI":"10.1073\/pnas.92.7.2909","article-title":"Induction of an outer surface protein on Borrelia burgdorferi during tick feeding","volume":"92","author":"Schwan","year":"1995","journal-title":"Proc Natl Acad Sci USA"},{"issue":"1","key":"10.1016\/j.vaccine.2006.07.052_bib20","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1128\/IAI.67.1.30-35.1999","article-title":"Influence of outer surface protein A antibody on Borrelia burgdorferi within feeding ticks","volume":"67","author":"de Silva","year":"1999","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2006.07.052_bib21","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1111\/j.1365-2958.1992.tb01495.x","article-title":"Molecular analysis and expression of a Borrelia burgdorferi gene encoding a 22kDa protein (pC) in Escherichia coli","volume":"6","author":"Fuchs","year":"1992","journal-title":"Mol Microbiol"},{"key":"10.1016\/j.vaccine.2006.07.052_bib22","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1128\/jb.175.4.926-932.1993","article-title":"Transcriptional analyses and mapping of the ospC gene in Lyme disease spirochetes","volume":"175","author":"Marconi","year":"1993","journal-title":"J Bacteriol"},{"key":"10.1016\/j.vaccine.2006.07.052_bib23","doi-asserted-by":"crossref","first-page":"2192","DOI":"10.1128\/IAI.61.5.2192-2195.1993","article-title":"The cryptic ospC gene of Borrelia burgdorferi B31 is located on a circular plasmid","volume":"61","author":"Sadziene","year":"1993","journal-title":"Infect Immun"},{"issue":"Pt 1","key":"10.1016\/j.vaccine.2006.07.052_bib24","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1042\/bst0310108","article-title":"Temporal regulation of outer surface proteins of the Lyme-disease spirochaete Borrelia burgdorferi","volume":"31","author":"Schwan","year":"2003","journal-title":"Biochem Soc Trans"},{"issue":"6","key":"10.1016\/j.vaccine.2006.07.052_bib25","doi-asserted-by":"crossref","first-page":"2234","DOI":"10.1128\/IAI.64.6.2234-2239.1996","article-title":"Outer surface protein C (OspC), but not P39 is a protective immunogen against a tick-transmitted Borrelia burgdorferi challenge: evidence for a conformational protective epitope in OspC","volume":"64","author":"Gilmore","year":"1996","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2006.07.052_bib26","doi-asserted-by":"crossref","first-page":"4661","DOI":"10.1128\/IAI.65.11.4661-4667.1997","article-title":"Borrelia burgdorferi strain-specific OspC mediated immunity in mice","volume":"65","author":"Bockenstedt","year":"1997","journal-title":"Infect Immun"},{"issue":"10","key":"10.1016\/j.vaccine.2006.07.052_bib27","doi-asserted-by":"crossref","first-page":"5463","DOI":"10.1128\/IAI.67.10.5463-5469.1999","article-title":"Conformational nature of the Borrelia burgdorferi B31 outer surface protein C protective epitope","volume":"67","author":"Gilmore","year":"1999","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2006.07.052_bib28","doi-asserted-by":"crossref","first-page":"4073","DOI":"10.1128\/IAI.66.9.4073-4079.1998","article-title":"The dominant epitope of Borrelia garinii outer surface protein C recognized by sera from patients with neuroborreliosis has a surface exposed conserved structural motif","volume":"66","author":"Mathiesen","year":"1998","journal-title":"Infect Immun"},{"issue":"11","key":"10.1016\/j.vaccine.2006.07.052_bib29","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/S1286-4579(03)00182-5","article-title":"A DNA vaccine encoding the outer surface protein C from Borrelia burgdorferi is able to induce protective immune responses","volume":"5","author":"Scheiblhofer","year":"2003","journal-title":"Microbes Infect"},{"key":"10.1016\/j.vaccine.2006.07.052_bib30","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1128\/CDLI.10.4.573-578.2003","article-title":"C-terminal region of outer surface protein C binds borreliacidal antibodies in sera from patients with Lyme disease","volume":"10","author":"Jobe","year":"2003","journal-title":"Clin Diagn Lab Immunol"},{"key":"10.1016\/j.vaccine.2006.07.052_bib31","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1086\/515382","article-title":"Borreliacidal antibody production against outer surface protein C of Borrelia burgdorferi","volume":"178","author":"Rousselle","year":"1998","journal-title":"J Infect Dis"},{"issue":"4","key":"10.1016\/j.vaccine.2006.07.052_bib32","doi-asserted-by":"crossref","first-page":"2130","DOI":"10.1128\/IAI.69.4.2130-2136.2001","article-title":"DNA vaccines expressing a fusion product of outer surface proteins A and C from Borrelia burgdorferi induce protective antibodies suitable for prophylaxis but not for resolution of Lyme disease","volume":"69","author":"Wallich","year":"2001","journal-title":"Infect Immun"},{"issue":"10","key":"10.1016\/j.vaccine.2006.07.052_bib33","doi-asserted-by":"crossref","first-page":"5470","DOI":"10.1128\/IAI.67.10.5470-5472.1999","article-title":"An OspC-specific monoclonal antibody passively protects mice from tick-transmitted infection by Borrelia burgdorferi B31","volume":"67","author":"Mbow","year":"1999","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2006.07.052_bib34","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1093\/infdis\/175.2.400","article-title":"Immunization with outer surface protein (Osp) A but not OspC provides cross-protection of mice challenged with North American isolates of Borrelia burgdorferi","volume":"175","author":"Probert","year":"1997","journal-title":"J Infect Dis"},{"issue":"28","key":"10.1016\/j.vaccine.2006.07.052_bib35","doi-asserted-by":"crossref","first-page":"3687","DOI":"10.1016\/j.vaccine.2005.02.006","article-title":"Multicomponent Lyme vaccine: three is not a crowd","volume":"23","author":"Brown","year":"2005","journal-title":"Vaccine"},{"issue":"5","key":"10.1016\/j.vaccine.2006.07.052_bib36","doi-asserted-by":"crossref","first-page":"1920","DOI":"10.1128\/IAI.62.5.1920-1926.1994","article-title":"Protection of C3H\/HeN mice from challenge with Borrelia burgdorferi through active immunization with OspA, OspB, or OspC, but not with OspD or the 83-kilodalton antigen","volume":"62","author":"Probert","year":"1994","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2006.07.052_bib37","doi-asserted-by":"crossref","first-page":"3518","DOI":"10.1128\/IAI.67.7.3518-3524.1999","article-title":"Four clones of Borrelia burgdorferi sensu stricto cause invasive infection in humans","volume":"67","author":"Seinost","year":"1999","journal-title":"Infect Immun"},{"issue":"1","key":"10.1016\/j.vaccine.2006.07.052_bib38","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1093\/genetics\/151.1.15","article-title":"Genetic diversity of ospC in a local population of Borrelia burgdorferi sensu stricto","volume":"151","author":"Wang","year":"1999","journal-title":"Genetics"},{"key":"10.1016\/j.vaccine.2006.07.052_bib39","doi-asserted-by":"crossref","first-page":"3036","DOI":"10.1128\/jb.177.11.3036-3044.1995","article-title":"Evolution of the Borrelia burgdorferi outer surface protein OspC","volume":"177","author":"Theisen","year":"1995","journal-title":"J Bacteriol"},{"key":"10.1016\/j.vaccine.2006.07.052_bib40","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1534\/genetics.104.028738","article-title":"Dykhuizen DE. ospC diversity in Borrelia burgdorferi: Different hosts are different niches","volume":"168","author":"Brisson","year":"2004","journal-title":"Genetics"},{"issue":"2","key":"10.1016\/j.vaccine.2006.07.052_bib41","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1086\/315269","article-title":"Stability of Borrelia burgdorferi outer surface protein C under immune selection pressure","volume":"181","author":"Hodzic","year":"2000","journal-title":"J Infect Dis"},{"issue":"8","key":"10.1016\/j.vaccine.2006.07.052_bib42","doi-asserted-by":"crossref","first-page":"3568","DOI":"10.1128\/IAI.62.8.3568-3571.1994","article-title":"Expression and gene sequence of outer surface protein C of Borrelia burgdorferi reisolated from chronically infected mice","volume":"62","author":"Stevenson","year":"1994","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2006.07.052_bib43","doi-asserted-by":"crossref","first-page":"7869","DOI":"10.1128\/IAI.73.12.7869-7877.2005","article-title":"Demonstration of OspC type diversity in invasive human Lyme disease isolates and identification of previously uncharacterized epitopes that define the specificity of the OspC antibody response","volume":"73","author":"Earnhart","year":"2005","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2006.07.052_bib44","unstructured":"Buckles EL, Earnhart CG, Marconi RT. Analysis of the antibody response in humans to the type A OspC loop 5 domain and assessment of the potential utility of the loop 5 epitope in Lyme disease vaccine development. Clin Vaccine Immunol, in press."},{"issue":"5","key":"10.1016\/j.vaccine.2006.07.052_bib45","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1093\/emboj\/20.5.971","article-title":"Crystal structure of outer surface protein C (OspC) from the Lyme disease spirochete Borrelia burgdorferi","volume":"20","author":"Kumaran","year":"2001","journal-title":"EMBO J"},{"key":"10.1016\/j.vaccine.2006.07.052_bib46","doi-asserted-by":"crossref","first-page":"10010","DOI":"10.1074\/jbc.M010062200","article-title":"Crystal structure of Lyme disease antigen outer surface protein C from Borrelia burgdorferi","volume":"276","author":"Eicken","year":"2001","journal-title":"J Biol Chem"},{"issue":"1","key":"10.1016\/j.vaccine.2006.07.052_bib47","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1074\/jbc.M008449200","article-title":"Structural conservation of neurotropism-associated VspA within the variable Borrelia Vsp-OspC lipoprotein family","volume":"276","author":"Zuckert","year":"2001","journal-title":"J Biol Chem"},{"issue":"3","key":"10.1016\/j.vaccine.2006.07.052_bib48","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1128\/IAI.68.3.1319-1327.2000","article-title":"Mutation and recombination in the upstream homology box flanked ospE related genes of the Lyme disease spirochetes results in the development of new antigenic variants during infection","volume":"68","author":"Sung","year":"2000","journal-title":"Infect Immun"},{"issue":"5","key":"10.1016\/j.vaccine.2006.07.052_bib49","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1093\/protein\/13.5.309","article-title":"LINKER: a program to generate linker sequences for fusion proteins","volume":"13","author":"Crasto","year":"2000","journal-title":"Protein Eng"},{"issue":"4","key":"10.1016\/j.vaccine.2006.07.052_bib50","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.1128\/JCM.43.4.1879-1884.2005","article-title":"Borrelia burgdorferi ospC heterogeneity among human and murine isolates from a defined region of Northern Maryland and Southern Pennsylvania: Lack of correlation with invasive and non-invasive genotypes","volume":"43","author":"Alghaferi","year":"2005","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.vaccine.2006.07.052_bib51","series-title":"The proteomics protocols handbook","first-page":"571","article-title":"Protein identification and analysis tools on the ExPASy server","author":"Gasteiger","year":"2005"},{"issue":"1","key":"10.1016\/j.vaccine.2006.07.052_bib52","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/0022-2836(90)90154-E","article-title":"Improvements in protein secondary structure prediction by an enhanced neural network","volume":"214","author":"Kneller","year":"1990","journal-title":"J Mol Biol"},{"issue":"2","key":"10.1016\/j.vaccine.2006.07.052_bib53","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1093\/protein\/4.2.155","article-title":"Correlation between stability of a protein and its dipeptide composition: a novel approach for predicting in vivo stability of a protein from its primary sequence","volume":"4","author":"Guruprasad","year":"1990","journal-title":"Protein Eng"},{"issue":"19","key":"10.1016\/j.vaccine.2006.07.052_bib54","doi-asserted-by":"crossref","first-page":"5544","DOI":"10.1128\/JB.183.19.5544-5553.2001","article-title":"Genetics and regulation of chitobiose utilization in Borrelia burgdorferi","volume":"183","author":"Tilly","year":"2001","journal-title":"J Bacteriol"},{"issue":"1","key":"10.1016\/j.vaccine.2006.07.052_bib55","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1111\/j.0269-283X.2005.00546.x","article-title":"Borreliacidal activity of saliva of the tick Amblyomma americanum","volume":"19","author":"Ledin","year":"2005","journal-title":"Med Vet Entomol"},{"issue":"10","key":"10.1016\/j.vaccine.2006.07.052_bib56","doi-asserted-by":"crossref","first-page":"2909","DOI":"10.1128\/JB.182.10.2909-2918.2000","article-title":"Altered stationary-phase response in a Borrelia burgdorferi rpoS mutant","volume":"182","author":"Elias","year":"2000","journal-title":"J Bacteriol"},{"issue":"4","key":"10.1016\/j.vaccine.2006.07.052_bib57","doi-asserted-by":"crossref","first-page":"2468","DOI":"10.1128\/IAI.74.4.2468-2472.2006","article-title":"Human neutrophil calprotectin reduces the susceptibility of Borrelia burgdorferi to penicillin","volume":"74","author":"Montgomery","year":"2006","journal-title":"Infect Immun"},{"issue":"4","key":"10.1016\/j.vaccine.2006.07.052_bib58","doi-asserted-by":"crossref","first-page":"2139","DOI":"10.1128\/IAI.70.4.2139-2150.2002","article-title":"Clonal polymorphism of Borrelia burgdorferi strain B31 MI: implications for mutagenesis in an infectious strain background","volume":"70","author":"Elias","year":"2002","journal-title":"Infect Immun"},{"issue":"4","key":"10.1016\/j.vaccine.2006.07.052_bib59","doi-asserted-by":"crossref","first-page":"2280","DOI":"10.1128\/IAI.72.4.2280-2287.2004","article-title":"Localization of BmpA on the exposed outer membrane of Borrelia burgdorferi by monospecific anti-recombinant BmpA rabbit antibodies","volume":"72","author":"Shin","year":"2004","journal-title":"Infect Immun"},{"issue":"Pt 7","key":"10.1016\/j.vaccine.2006.07.052_bib60","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1099\/jmm.0.05068-0","article-title":"Inability of outer-surface protein C (OspC)-primed mice to elicit a protective anamnestic immune response to a tick-transmitted challenge of Borrelia burgdorferi","volume":"52","author":"Gilmore","year":"2003","journal-title":"J Med Microbiol"},{"key":"10.1016\/j.vaccine.2006.07.052_bib61","series-title":"New generation vaccines","article-title":"Vaccines against Lyme disease","author":"Hanson","year":"2004"},{"issue":"13","key":"10.1016\/j.vaccine.2006.07.052_bib62","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1016\/j.micinf.2005.04.020","article-title":"Chimeric epitopes delivered by polymeric synthetic linear peptides induce protective immunity to malaria","volume":"7","author":"Caro-Aguilar","year":"2005","journal-title":"Microbes Infect"},{"issue":"8","key":"10.1016\/j.vaccine.2006.07.052_bib63","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1086\/444458","article-title":"Safety and immunogenicity of 26-valent group a streptococcus vaccine in healthy adult volunteers","volume":"41","author":"McNeil","year":"2005","journal-title":"Clin Infect Dis"},{"issue":"7","key":"10.1016\/j.vaccine.2006.07.052_bib64","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1128\/CDLI.12.7.833-836.2005","article-title":"Multivalent group A streptococcal vaccine elicits bactericidal antibodies against variant M subtypes","volume":"12","author":"Dale","year":"2005","journal-title":"Clin Diagn Lab Immunol"},{"issue":"4","key":"10.1016\/j.vaccine.2006.07.052_bib65","doi-asserted-by":"crossref","first-page":"2171","DOI":"10.1128\/IAI.70.4.2171-2177.2002","article-title":"Immunogenicity of a 26-valent group A streptococcal vaccine","volume":"70","author":"Hu","year":"2002","journal-title":"Infect Immun"},{"issue":"2","key":"10.1016\/j.vaccine.2006.07.052_bib66","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/S0264-410X(98)00150-9","article-title":"Multivalent group A streptococcal vaccine designed to optimize the immunogenicity of six tandem M protein fragments","volume":"17","author":"Dale","year":"1999","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2006.07.052_bib67","first-page":"738","article-title":"Safety and immunogenicity of a recombinant multivalent group a streptococcal vaccine in healthy adults: phase 1 trial","volume":"292","author":"Kotloff","year":"2005","journal-title":"JAMA"},{"key":"10.1016\/j.vaccine.2006.07.052_bib68","doi-asserted-by":"crossref","first-page":"4100","DOI":"10.1021\/jm040041w","article-title":"Toward the development of a synthetic group A streptococcal vaccine of high purity and broad protective coverage","volume":"47","author":"Horvath","year":"2005","journal-title":"J Med Chem"},{"issue":"3","key":"10.1016\/j.vaccine.2006.07.052_bib69","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.vaccine.2005.07.100","article-title":"Tetravalent neutralizing antibody response against four dengue serotypes by a single chimeric dengue envelope antigen","volume":"24","author":"Apt","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2006.07.052_bib70","doi-asserted-by":"crossref","first-page":"4453","DOI":"10.1016\/j.vaccine.2005.03.044","article-title":"Co-immunization of BALB\/c mice with recombinant immunogens containing G protein fragment and chimeric CTL epitope of respiratory syncytial virus induces enhanced cellular immunity and high level of antibody response","volume":"23","author":"Fan","year":"2005","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2006.07.052_bib71","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1089\/vim.2005.18.549","article-title":"Identification of neutralizing epitopes on the VP2 protein of infectious bursal disease virus by phage-displayed heptapeptide library screening and synthetic peptide mapping","volume":"18","author":"Wang","year":"2005","journal-title":"Viral Immunol"},{"issue":"17\u201318","key":"10.1016\/j.vaccine.2006.07.052_bib72","doi-asserted-by":"crossref","first-page":"2074","DOI":"10.1016\/j.vaccine.2005.01.011","article-title":"Induction of broadly neutralizing antibodies against measles virus mutants using a polyepitope vaccine strategy","volume":"23","author":"Bouche","year":"2005","journal-title":"Vaccine"},{"issue":"6","key":"10.1016\/j.vaccine.2006.07.052_bib73","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1128\/CDLI.12.6.746-751.2005","article-title":"Borreliacidal OspC antibodies specific for a highly conserved epitope are immunodominant in human Lyme disease and do not occur in mice or hamsters","volume":"12","author":"Lovrich","year":"2005","journal-title":"Clin Diagn Lab Immunol"},{"issue":"Suppl. 40","key":"10.1016\/j.vaccine.2006.07.052_bib74","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.ijmm.2006.01.005","article-title":"Comparison of isolation rate of Borrelia burgdorferi sensu lato in MKP and BSK-II medium","volume":"296","author":"Ruzic-Sabljic","year":"2006","journal-title":"Int J Med Microbiol"},{"issue":"11","key":"10.1016\/j.vaccine.2006.07.052_bib75","doi-asserted-by":"crossref","first-page":"5709","DOI":"10.1128\/IAI.67.11.5709-5716.1999","article-title":"Population dynamics of a naturally occurring heterogeneous mixture of Borrelia burgdorferi clones","volume":"67","author":"Hofmeister","year":"1999","journal-title":"Infect Immun"},{"issue":"3","key":"10.1016\/j.vaccine.2006.07.052_bib76","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1128\/JCM.34.3.652-656.1996","article-title":"Multiple infections of Ixodes scapularis ticks by Borrelia burgdorferi as revealed by single-strand conformation polymorphism analysis","volume":"34","author":"Guttman","year":"1996","journal-title":"J Clin Microbiol"},{"issue":"1","key":"10.1016\/j.vaccine.2006.07.052_bib77","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1111\/j.1469-0691.1997.tb00259.x","article-title":"Detection of Borrelia afzelii, Borrelia burgdorferi sensu stricto, Borrelia garinii and group VS116 by PCR in skin biopsies of patients with erythema migrans and acrodermatitis chronica atrophicans","volume":"3","author":"Rijpkema","year":"1997","journal-title":"Clin Microbiol Infect"},{"issue":"4","key":"10.1016\/j.vaccine.2006.07.052_bib78","doi-asserted-by":"crossref","first-page":"2188","DOI":"10.4049\/jimmunol.151.4.2188","article-title":"Recombinant tetravalent group A streptococcal M protein vaccine","volume":"151","author":"Dale","year":"1993","journal-title":"J Immunol"},{"issue":"10","key":"10.1016\/j.vaccine.2006.07.052_bib79","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1016\/0264-410X(96)00050-3","article-title":"Recombinant, octavalent group A streptococcal M protein vaccine","volume":"14","author":"Dale","year":"1996","journal-title":"Vaccine"},{"issue":"10","key":"10.1016\/j.vaccine.2006.07.052_bib80","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1099\/0022-1317-49-10-917","article-title":"Borreliacidal activity of early Lyme disease sera against complement-resistant Borrelia afzelii FEM1 wild-type and an OspC-lacking FEM1 variant","volume":"49","author":"Kraiczy","year":"2000","journal-title":"J Med Microbiol"},{"issue":"10","key":"10.1016\/j.vaccine.2006.07.052_bib81","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1086\/382893","article-title":"Borrelia-specific interferon-gamma and interleukin-4 secretion in cerebrospinal fluid and blood during Lyme borreliosis in humans: association with clinical outcome","volume":"189","author":"Widhe","year":"2004","journal-title":"J Infect Dis"},{"issue":"4","key":"10.1016\/j.vaccine.2006.07.052_bib82","doi-asserted-by":"crossref","first-page":"2020","DOI":"10.4049\/jimmunol.155.4.2020","article-title":"Role of IL-4 and IFN-gamma in modulation of immunity to Borrelia burgdorferi in mice","volume":"155","author":"Keane-Myers","year":"1995","journal-title":"J Immunol"},{"issue":"7","key":"10.1016\/j.vaccine.2006.07.052_bib83","doi-asserted-by":"crossref","first-page":"2488","DOI":"10.4049\/jimmunol.156.7.2488","article-title":"Recombinant IL-4 treatment augments resistance to Borrelia burgdorferi infections in both normal susceptible and antibody-deficient susceptible mice","volume":"156","author":"Keane-Myers","year":"1996","journal-title":"J Immunol"},{"issue":"4","key":"10.1016\/j.vaccine.2006.07.052_bib84","doi-asserted-by":"crossref","first-page":"1770","DOI":"10.4049\/jimmunol.154.4.1770","article-title":"T cell subset-dependent modulation of immunity to Borrelia burgdorferi in mice","volume":"154","author":"Keane-Myers","year":"1995","journal-title":"J Immunol"},{"issue":"3\u20134","key":"10.1016\/j.vaccine.2006.07.052_bib85","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1007\/s002510050595","article-title":"SYFPEITHI: database for MHC ligands and peptide motifs","volume":"50","author":"Rammensee","year":"1999","journal-title":"Immunogenetics"},{"key":"10.1016\/j.vaccine.2006.07.052_bib86","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1093\/nar\/gki452","article-title":"MULTIPRED: a computational system for prediction of promiscuous HLA binding peptides","volume":"33 (W)","author":"Zhang","year":"2005","journal-title":"Nucleic Acids Res"},{"issue":"8","key":"10.1016\/j.vaccine.2006.07.052_bib87","first-page":"686","article-title":"Effects of the configuration of a multi-epitope chimeric malaria DNA vaccine on its antigenicity to mice","volume":"112","author":"Jiang","year":"1999","journal-title":"Chin Med J (Engl)"},{"issue":"1","key":"10.1016\/j.vaccine.2006.07.052_bib88","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/S0264-410X(97)00155-2","article-title":"Immunogenicity of chimeric multiple antigen peptides based on Plasmodium falciparum antigens: impact of epitope orientation","volume":"16","author":"Ahlborg","year":"1998","journal-title":"Vaccine"},{"issue":"8\u20139","key":"10.1016\/j.vaccine.2006.07.052_bib89","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/S0161-5890(97)00078-3","article-title":"Tandem repeats of T helper epitopes enhance immunogenicity of fusion proteins by promoting processing and presentation","volume":"34","author":"Kjerrulf","year":"1997","journal-title":"Mol Immunol"},{"issue":"1\u20132","key":"10.1016\/j.vaccine.2006.07.052_bib90","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/S0022-1759(00)00197-6","article-title":"Differential antigenicity of recombinant polyepitope-antigens based on loop- and helix-forming B and T cell epitopes","volume":"242","author":"Theisen","year":"2000","journal-title":"J Immunol Methods"},{"issue":"12","key":"10.1016\/j.vaccine.2006.07.052_bib91","doi-asserted-by":"crossref","first-page":"7077","DOI":"10.4049\/jimmunol.151.12.7077","article-title":"Role of adjuvants in the modulation of antibody isotype, specificity and induction of protection by whole blood-stage Plasmodium yoelii vaccines","volume":"151","author":"ten Hagen","year":"1993","journal-title":"J Immunol"},{"issue":"5","key":"10.1016\/j.vaccine.2006.07.052_bib92","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1111\/j.0818-9641.2004.01286.x","article-title":"Aluminium compounds for use in vaccines","volume":"82","author":"Lindblad","year":"2004","journal-title":"Immunol Cell Biol"},{"issue":"5","key":"10.1016\/j.vaccine.2006.07.052_bib93","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1111\/j.0818-9641.2004.01272.x","article-title":"Vaccine adjuvants: current state and future trends","volume":"82","author":"Petrovsky","year":"2004","journal-title":"Immunol Cell Biol"},{"issue":"12","key":"10.1016\/j.vaccine.2006.07.052_bib94","doi-asserted-by":"crossref","first-page":"6448","DOI":"10.4049\/jimmunol.163.12.6448","article-title":"Aluminium hydroxide adjuvant initiates strong antigen-specific Th2 responses in the absence of IL-4- or IL-13-mediated signaling","volume":"163","author":"Brewer","year":"1999","journal-title":"J Immunol"},{"issue":"1\u20133","key":"10.1016\/j.vaccine.2006.07.052_bib95","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S0169-409X(01)00169-7","article-title":"Manipulating the immune system: humoral versus cell-mediated immunity","volume":"51","author":"McNeela","year":"2001","journal-title":"Adv Drug Deliv Rev"},{"issue":"12","key":"10.1016\/j.vaccine.2006.07.052_bib96","doi-asserted-by":"crossref","first-page":"8119","DOI":"10.1128\/IAI.73.12.8119-8129.2005","article-title":"Epitope-specific regulation of immunoglobulin class switching in mice immunized with malarial merozoite surface proteins","volume":"73","author":"Tongren","year":"2005","journal-title":"Infect Immun"},{"issue":"2","key":"10.1016\/j.vaccine.2006.07.052_bib97","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.vaccine.2004.04.007","article-title":"Immunogenicity of polyepitope libraries assembled by epitope shuffling: an approach to the development of chimeric gene vaccination against malaria","volume":"23","author":"Cai","year":"2004","journal-title":"Vaccine"},{"issue":"23","key":"10.1016\/j.vaccine.2006.07.052_bib98","doi-asserted-by":"crossref","first-page":"12533","DOI":"10.1073\/pnas.94.23.12533","article-title":"Therapeutic passive vaccination against chronic Lyme disease in mice","volume":"94","author":"Zhong","year":"1997","journal-title":"Proc Natl Acad Sci USA"},{"issue":"1","key":"10.1016\/j.vaccine.2006.07.052_bib99","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1128\/JCM.38.1.382-388.2000","article-title":"Temporal changes in outer surface proteins A and C of the Lyme disease-associated spirochete, Borrelia burgdorferi, during the chain of infection in ticks and mice","volume":"38","author":"Schwan","year":"2000","journal-title":"J Clin Microbiol"},{"issue":"3","key":"10.1016\/j.vaccine.2006.07.052_bib100","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1007\/BF01781105","article-title":"Tick factors and in vitro cultivation influence the protein profile, antigenicity and pathogenicity of a cloned Borrelia garinii isolate from Ixodes ricinus hemolymph","volume":"24","author":"Hu","year":"1996","journal-title":"Infection"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X0600911X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X0600911X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,5,8]],"date-time":"2023-05-08T13:07:41Z","timestamp":1683551261000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X0600911X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,1]]},"references-count":100,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2007,1]]}},"alternative-id":["S0264410X0600911X"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2006.07.052","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2007,1]]}}}